IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS - ANVISA Registration 10287410860
Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287410860 and manufactured by manufacturer not specified. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Mar 08, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including VENTANA MEDICAL SYSTEM, INC, LEICA BIOSYSTEMS NEWCASTLE LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
10287410860
25351587609200968
30280358000186
Company Information
Dates and Status
Mar 08, 2010
08/03/2035
09/18/2025 19:00:01
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
Not specified
10337990034
Jul 02, 2018
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990034
Jul 02, 2018
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA DE MARCADORES DE LINFOMAS E LEUCEMIAS
CELL MARQUE CORPORATION
80358430003
Oct 04, 2010
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA DE MARCADORES DE LINFOMAS E LEUCEMIAS
Not specified
80358430003
Oct 04, 2010
LYMPHOMA AND LEUKEMIA MARKERS
Familia Linfoma (Roche)
ROCHE DIAGNOSTICS GMBH
10287411746
May 05, 2025
VENTANA MEDICAL SYSTEM, INC• United States of America
LEICA BIOSYSTEMS NEWCASTLE LTD• United Kingdom
CELL MARQUE CORPORATION• United States of America
AGILENT TECHNOLOGIES, INC.• United States of America
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.• Singapore
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Anti-CD8 (SP239) Rabbit Monoclonal Primary Antibody
VENTANA MEDICAL SYSTEM, INC
10287411688
Mar 25, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Anti-CD8 (SP239) Rabbit Monoclonal Primary Antibody
Not specified
10287411688
Mar 25, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
Not specified
10337990034
Jul 02, 2018
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990034
Jul 02, 2018
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Família Marcador de Carcinoma de Linfoma e Leucemia
Not specified
80000230036
Dec 26, 2016